CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia to deliver bioactive molecules to treat diseases associated with the human gut microbiome.
CHAIN Biotechnology is a biotechnology company using microbial technologies to develop healthcare products that is headquartered in Marlow, United Kingdom and was founded in 2014 by Basil Omar and Edward Green.
On September 12, 2017 CHAIN Biotechnology received a grant worth £500,000 from Innovative UK.
CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.